Alnylam Pharmaceuticals (ALNY) PT Raised to $205 at Needham & Company Following R&D Day
Tweet Send to a Friend
Needham & Company analyst Joseph Stringer raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $205.00 (from $180.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
